AspenBio Pharma Announces Closing of Public Offering of 1.946M Shares of Common Stock
Posted on November 20, 2012 at 16:10 PM EST
AspenBio Pharma (NASDAQ: APPY ), an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share. After underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds from the